Abstract Submission Guidelines
Abstract submission deadline: March 1, 2020, 11:59PM CST.
An individual may be the first author on a maximum of three (3) abstracts.
An individual may be a contributing author on an unlimited number of abstracts.
All submitted abstracts become the property of MDS.
Format
Text limit of 2,500 characters (including spaces). The size limit includes characters and spaces in the Abstract Title and Abstract Body. Please note that spaces are included in the overall character count. The size limit does not include author information.
Abstracts should be arranged as follows:
- Objective
- Background
- Methods
- Results
- Conclusions
*You may submit a case report using the standard abstract format
Do not include any identifying information directly on the abstract.
Only non-proprietary (generic) drug names should be used and should be written without capitals.
Do not include branded product names in the abstract. If the abstract is found to contain marketing, rather than scientific content, the abstract will be rejected.
Select one (1) category under which the abstract should be reviewed. If the abstract covers more than one topic, please choose the most appropriate category and indicate additional related topics via corresponding keywords. This will aid online searches and further organization of your abstract within the listed category (see “Review and Categorization” regarding re-categorizing a submitted abstract).
The use of standard abbreviations is desirable. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands.
Please note there is a separate upload field for tables and graphs. To include tables or figures, enter the appropriate ID tag within the abstract body where the tables and/or figures should appear. Tags must be entered as shown - [table1] for your first table; [table2] for your second table; [figure1] for your first figure; [figure2] for your second figure.
To list references, enter the appropriate ID tag. [1] for your first reference, [2] for your second reference, [3] for your third reference, etc.
Submission and Eligibility
Abstract submissions must be received by March 1, 2020, 11:59PM CST.
The sole means of submission is via the Internet. Please do not e-mail, fax, or mail abstract submissions.
Abstracts must be submitted and presented in English.
MDS members and non-members are eligible to submit abstracts.
There is no fee for submitting an MDS abstract.
MDS does not offer CME credit for poster viewing or submitted abstracts.
MDS International Congress faculty are not required to submit an abstract.
MDS expects that all accepted abstracts will be presented during the scheduled poster session time during the 2020 International Congress and that no submitted abstracts will be withdrawn. Please do not submit an abstract unless you are prepared to travel to the 2020 International Congress to present your abstract as a printed poster as scheduled by MDS.
All abstract presenters are required to register and pay applicable registration fees to attend the MDS International Congress.
Review and Categorization
The MDS Congress Scientific Program Committee will review all abstracts in March of 2020. The Committee shall be directed to reject abstracts for the following reasons:
- Plagiarism detected
- Marketing detected
- Subject not related to the field of Movement Disorders
- Does not meet basic requirements
All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected.
If it is determined by the Congress Scientific Program Committee that a submitted abstract is not entered in the optimal abstract category listing, MDS reserves the right to re-categorize the abstract on behalf of the author(s) without prior notification. The new category placement will be confirmed in the official abstract notification letter.
If it is determined that the abstract should be re-categorized, MDS will ensure that the new category placement is in the best interest of the work and easily searchable by International Congress attendees as well as online researchers.
Notification and Correspondence
All notifications regarding a saved or submitted abstract will be sent only to the person identified as ‘Contact for Official Abstract Correspondence’. It is expected that the designated contact person will circulate updates regarding the abstract as needed.
All successfully submitted abstracts will receive a confirmation e-mail to the designated contact person. If the confirmation e-mail has not been received within 24-hours of submitting the abstract, please log in to the abstract submission site to verify the status of the submission.
Abstract acceptance notifications will be sent to the designated contact person via e-mail in May 2020.
An official abstract notification letter will be available through the submission site and can be downloaded and printed at any time after notifications have been sent in May 2020.
All confirmed abstract submissions will be reviewed for acceptance by MDS.
Abstracts with a status of ‘saved’ are not confirmed submissions and will not be reviewed by MDS.
Please ensure that noreply@omnipress.com and congress@movementdisorders.org are designated as a “safe senders” to ensure timely correspondence regarding the abstract submission.
Please check your spam and junk e-mail folders before contacting MDS regarding the status of your abstract. Abstract notices will come from noreply@omnipress.com or congress@movementdisorders.org.
Abstract status can also be checked directly on the submission site in May 2020.
Withdrawing a Submitted Abstract
If you prefer not to publish your abstract or case study without the opportunity to present your work in person, please withdraw your submission by JULY 1, 2020 by visiting https://catalyst.omnipress.com. There is no penalty or consequence to withdraw your work, and you are welcome to resubmit a withdrawn submission for a future MDS International Congress.
December 2, 2019 – March 1, 2020
You may withdraw a submitted abstract at any time while submission is still open (before March 1, 2020). To withdraw an abstract, simply log in to your submission and click on 'Withdraw'. There is no penalty to withdraw your abstract.
March 2 – July 1, 2020
Requests to withdraw a submitted abstract after the submission deadline (March 1, 2020) must be submitted online at https://catalyst.omnipress.com, or received in writing by July 1, 2020, to congress@movementdisorders.org.
July 1, 2020 – Onward
After July 2, 2020, your abstract cannot be withdrawn and will remain a part of the 2020 MDS published abstracts. All submitted abstracts become the property of MDS.
Publication of Accepted Abstracts
All accepted abstracts will be published in an electronic supplement to the Movement Disorders journal online edition. All submitted abstracts become the property of MDS.
MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or as a group. Should plagiarism be detected, the abstract will be rejected
Abstract Presentation
All accepted abstracts will be offered the opportunity to submit a PDF of their poster for presentation as an e-poster in the MDS Virtual Congress 2020 poster catalog. Detailed information can be found in the abstract submission notification letter or by logging in to your abstract profile at https://catalyst.omnipress.com after May 30, 2020.
Abstracts scoring in the top 10% will be offered the opportunity to present in a virtual session. Details will be sent directly to selected abstract contacts. Please watch for further information and announcements via email and social media in the coming months.
If you prefer not to publish your abstract or case study without the opportunity to present your work in person, please withdraw your submission by JULY 1, 2020 by visiting https://catalyst.omnipress.com. There is no penalty or consequence to withdraw your work, and you are welcome to resubmit a withdrawn submission for a future MDS International Congress.
Previously Published Abstracts and Plagiarism
All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected.
Abstracts that have been presented at other meetings may be submitted if they have not been previously published. Submitted abstracts that have been presented at other meetings must include the previous meeting name and presentation date cited accordingly in the abstract body, after the Conclusion.
If the abstract is found to have been previously published in another MDS publication or a previous edition of the Movement Disorders journal, the designated contact person will be notified. The International Congress does not accept encore abstracts.
All abstracts presented at a previous MDS International Congress have been published by MDS.